{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T23:05:11Z","timestamp":1787871911061,"version":"build-2784847793"},"reference-count":214,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,28]],"date-time":"2026-02-28T00:00:00Z","timestamp":1772236800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimica et Biophysica Acta (BBA) - Reviews on Cancer"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.bbcan.2026.189568","type":"journal-article","created":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T15:52:11Z","timestamp":1772207531000},"page":"189568","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Cancer-associated fibroblasts in non-small cell lung cancer therapy: Challenges and opportunities"],"prefix":"10.1016","volume":"1881","author":[{"given":"Siyou","family":"Deng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinjie","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbcan.2026.189568_bb0005","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.bbcan.2026.189568_bb0010","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.lungcan.2013.07.025","article-title":"Genetic alterations defining NSCLC subtypes and their therapeutic implications","volume":"82","author":"Pikor","year":"2013","journal-title":"Lung Cancer"},{"key":"10.1016\/j.bbcan.2026.189568_bb0015","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/S0025-6196(11)60735-0","article-title":"Non-small cell lung cancer: epidemiology, risk factors, treatment, and survivorship","volume":"83","author":"Molina","year":"2008","journal-title":"Mayo Clin. Proc."},{"key":"10.1016\/j.bbcan.2026.189568_bb0020","first-page":"239","article-title":"Erlotinib versus standard chemotherapy as first-line treatment for European patients with advanced EGFR mutation-positive non-small-cell lung cancer (EURTAC): a multicentre, open-label, randomised phase 3 trial","volume":"13","author":"Rosell","year":"2012"},{"key":"10.1016\/j.bbcan.2026.189568_bb0025","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1056\/NEJMoa011954","article-title":"Comparison of four chemotherapy regimens for advanced non\u2013small-cell lung cancer","volume":"346","author":"Schiller","year":"2002","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bbcan.2026.189568_bb0030","doi-asserted-by":"crossref","first-page":"6167","DOI":"10.1002\/cam4.4192","article-title":"EGFR-mutated stage IV non-small cell lung cancer: what is the role of radiotherapy combined with TKI?","volume":"10","author":"Liu","year":"2021","journal-title":"Cancer Med."},{"key":"10.1016\/j.bbcan.2026.189568_bb0035","doi-asserted-by":"crossref","first-page":"4592","DOI":"10.1158\/1078-0432.CCR-18-1538","article-title":"Immunotherapy in non\u2013small cell lung cancer: facts and hopes","volume":"25","author":"Doroshow","year":"2019","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.bbcan.2026.189568_bb0040","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1038\/s41571-025-01021-1","article-title":"Tumour and microenvironment crosstalk in NSCLC progression and response to therapy","volume":"22","author":"Rahal","year":"2025","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.bbcan.2026.189568_bb0045","doi-asserted-by":"crossref","DOI":"10.1186\/s12943-019-0994-2","article-title":"Cancer-associated fibroblasts as abettors of tumor progression at the crossroads of EMT and therapy resistance","volume":"18","author":"Fiori","year":"2019","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.bbcan.2026.189568_bb0050","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-019-10968-6","article-title":"CAF hierarchy driven by pancreatic cancer cell p53-status creates a pro-metastatic and chemoresistant environment via perlecan","volume":"10","author":"Vennin","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bbcan.2026.189568_bb0055","first-page":"158","article-title":"Prognostic impact of cancer-associated active fibroblasts and invasive architectural patterns on early-stage lung adenocarcinoma","volume":"145","author":"Yotsukura","year":"2020"},{"key":"10.1016\/j.bbcan.2026.189568_bb0060","doi-asserted-by":"crossref","DOI":"10.1186\/s12931-020-01490-1","article-title":"Presence of heat shock protein 47-positive fibroblasts in cancer stroma is associated with increased risk of postoperative recurrence in patients with lung cancer","volume":"21","author":"Miyamura","year":"2020","journal-title":"Respir. Res."},{"key":"10.1016\/j.bbcan.2026.189568_bb0065","first-page":"151","article-title":"Stromal markers of activated tumor associated fibroblasts predict poor survival and are associated with necrosis in non-small cell lung cancer","volume":"135","author":"Alcaraz","year":"2019","journal-title":"u"},{"key":"10.1016\/j.bbcan.2026.189568_bb0070","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1097\/JTO.0b013e3181f8a1bd","article-title":"The role of tumor stroma in cancer progression and prognosis: emphasis on carcinoma-associated fibroblasts and non-small cell lung cancer","volume":"6","author":"Bremnes","year":"2011","journal-title":"J. Thorac. Oncol."},{"key":"10.1016\/j.bbcan.2026.189568_bb0075","doi-asserted-by":"crossref","first-page":"6239","DOI":"10.1038\/s41467-022-33862-0","article-title":"Tumor-produced and aging-associated oncometabolite methylmalonic acid promotes cancer-associated fibroblast activation to drive metastatic progression","volume":"13","author":"Li","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bbcan.2026.189568_bb0080","doi-asserted-by":"crossref","first-page":"5142","DOI":"10.1158\/0008-5472.CAN-16-2586","article-title":"Cancer-associated fibroblasts share characteristics and protumorigenic activity with mesenchymal stromal cells","volume":"77","author":"Borriello","year":"2017","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbcan.2026.189568_bb0085","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1172\/JCI0215518","article-title":"Evidence that fibroblasts derive from epithelium during tissue fibrosis","volume":"110","author":"Iwano","year":"2002","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbcan.2026.189568_bb0090","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1093\/qjmed\/hcz093","article-title":"Snail1-dependent cancer-associated fibroblasts induce epithelial-mesenchymal transition in lung cancer cells via exosomes","volume":"112","author":"You","year":"2019","journal-title":"Qjm"},{"key":"10.1016\/j.bbcan.2026.189568_bb0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellsig.2020.109675","article-title":"MiR-210 in exosomes derived from CAFs promotes non-small cell lung cancer migration and invasion through PTEN\/PI3K\/AKT pathway","volume":"73","author":"Yang","year":"2020","journal-title":"Cell. Signal."},{"key":"10.1016\/j.bbcan.2026.189568_bb0100","doi-asserted-by":"crossref","DOI":"10.3390\/ijms232415576","article-title":"Dual role of fibroblasts educated by tumour in cancer behavior and therapeutic perspectives","volume":"23","author":"Toledo","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbcan.2026.189568_bb0105","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.cytogfr.2016.09.002","article-title":"Endothelial-to-mesenchymal transition: cytokine-mediated pathways that determine endothelial fibrosis under inflammatory conditions","volume":"33","author":"P\u00e9rez","year":"2017","journal-title":"Cytokine Growth Factor Rev."},{"key":"10.1016\/j.bbcan.2026.189568_bb0110","doi-asserted-by":"crossref","first-page":"E5618","DOI":"10.1073\/pnas.1608384113","article-title":"Pericyte-fibroblast transition promotes tumor growth and metastasis","volume":"113","author":"Hosaka","year":"2016","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.bbcan.2026.189568_bb0115","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1038\/labinvest.2015.100","article-title":"ROS-induced endothelial stress contributes to pulmonary fibrosis through pericytes and Wnt signaling","volume":"96","author":"Andersson-Sj\u00f6land","year":"2016","journal-title":"Lab. Investig."},{"key":"10.1016\/j.bbcan.2026.189568_bb0120","article-title":"Smad3 promotes cancer-associated fibroblasts generation via macrophage-Myofibroblast transition","volume":"9","author":"Tang","year":"2022","journal-title":"Adv. Sci. (Weinh.)"},{"key":"10.1016\/j.bbcan.2026.189568_bb0125","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202470006","article-title":"Hematopoietic transcription factor RUNX1 is essential for promoting macrophage-myofibroblast transition in non-small-cell lung carcinoma","volume":"11","author":"Tang","year":"2024","journal-title":"Adv. Sci."},{"key":"10.1016\/j.bbcan.2026.189568_bb0130","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1136\/gutjnl-2024-333638","article-title":"Endothelial-like cancer-associated fibroblasts facilitate pancreatic cancer metastasis via vasculogenic mimicry and paracrine signalling","volume":"74","author":"Sun","year":"2025","journal-title":"Gut"},{"key":"10.1016\/j.bbcan.2026.189568_bb0135","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1158\/2159-8290.CD-23-0426","article-title":"Senescent CAFs mediate immunosuppression and drive breast cancer progression","volume":"14","author":"Ye","year":"2024","journal-title":"Cancer Discov."},{"key":"10.1016\/j.bbcan.2026.189568_bb0140","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.ccell.2018.01.011","article-title":"Fibroblast heterogeneity and immunosuppressive environment in human breast Cancer","volume":"33","author":"Costa","year":"2018","journal-title":"Cancer Cell"},{"key":"10.1016\/j.bbcan.2026.189568_bb0145","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2020.107628","article-title":"Single-cell RNA sequencing reveals a dynamic stromal niche that supports tumor growth","volume":"31","author":"Davidson","year":"2020","journal-title":"Cell Rep."},{"key":"10.1016\/j.bbcan.2026.189568_bb0150","series-title":"Phenotype Molding of Stromal Cells in the Lung Tumor Microenvironment","first-page":"1277","volume":"vol. 24","author":"Lambrechts","year":"2018"},{"key":"10.1016\/j.bbcan.2026.189568_bb0155","article-title":"Identification and characterization of cancer-associated fibroblast subpopulations in lung adenocarcinoma","volume":"14","author":"Kim","year":"2022","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.bbcan.2026.189568_bb0160","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1186\/s12943-025-02287-w","article-title":"Single-cell and spatial transcriptomic analyses revealing tumor microenvironment remodeling after neoadjuvant chemoimmunotherapy in non-small cell lung cancer","volume":"24","author":"Cui","year":"2025","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.bbcan.2026.189568_bb0165","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20210815","article-title":"Lung tumor MHCII immunity depends on in situ antigen presentation by fibroblasts","volume":"219","author":"Kerdidani","year":"2022","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.bbcan.2026.189568_bb0170","doi-asserted-by":"crossref","first-page":"2606","DOI":"10.1158\/2159-8290.CD-21-1714","article-title":"Spatial positioning and matrix programs of cancer-associated fibroblasts promote T-cell exclusion in human lung tumors","volume":"12","author":"Grout","year":"2022","journal-title":"Cancer Discov."},{"key":"10.1016\/j.bbcan.2026.189568_bb0175","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-023-43296-3","article-title":"Cancer-associated fibroblasts in early-stage lung adenocarcinoma correlate with tumor aggressiveness","volume":"13","author":"Vasiukov","year":"2023","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbcan.2026.189568_bb0180","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1038\/s41467-023-35832-6","article-title":"Single-cell analysis reveals prognostic fibroblast subpopulations linked to molecular and immunological subtypes of lung cancer","volume":"14","author":"Hanley","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bbcan.2026.189568_bb0185","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.ccell.2023.12.021","article-title":"Cancer-associated fibroblast phenotypes are associated with patient outcome in non-small cell lung cancer","volume":"42","author":"Cords","year":"2024","journal-title":"Cancer Cell"},{"key":"10.1016\/j.bbcan.2026.189568_bb0190","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.1038\/s41416-024-02671-1","article-title":"Cancer-associated fibroblasts expressing fibroblast activation protein and podoplanin in non-small cell lung cancer predict poor clinical outcome","volume":"130","author":"Mathieson","year":"2024","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.bbcan.2026.189568_bb0195","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/j.neo.2019.03.009","article-title":"Characterization of distinct populations of carcinoma-associated fibroblasts from non\u2013small cell lung carcinoma reveals a role for ST8SIA2 in cancer cell invasion","volume":"21","author":"Hao","year":"2019","journal-title":"Neoplasia"},{"key":"10.1016\/j.bbcan.2026.189568_bb0200","doi-asserted-by":"crossref","DOI":"10.1002\/ctm2.1605","article-title":"Distinct fibroblast subpopulations associated with bone, brain or intrapulmonary metastasis in advanced non-small-cell lung cancer","volume":"14","author":"Xu","year":"2024","journal-title":"Clin. Transl. Med."},{"key":"10.1016\/j.bbcan.2026.189568_bb0205","doi-asserted-by":"crossref","first-page":"2423","DOI":"10.1007\/s00262-023-03428-0","article-title":"Integrative analyses of bulk and single-cell RNA-seq identified cancer-associated fibroblasts-related signature as a prognostic factor for immunotherapy in NSCLC","volume":"72","author":"Wang","year":"2023","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.bbcan.2026.189568_bb0210","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1038\/s41588-024-01998-y","article-title":"Multi-omic profiling highlights factors associated with resistance to immuno-chemotherapy in non-small-cell lung cancer","volume":"57","author":"Yan","year":"2025","journal-title":"Nat. Genet."},{"key":"10.1016\/j.bbcan.2026.189568_bb0215","article-title":"Spatially resolved transcriptomics reveal the determinants of primary resistance to immunotherapy in NSCLC with mature tertiary lymphoid structures","volume":"6","author":"Peyraud","year":"2025","journal-title":"Cell Rep. Med."},{"key":"10.1016\/j.bbcan.2026.189568_bb0220","doi-asserted-by":"crossref","DOI":"10.1002\/ctm2.1515","article-title":"Single-cell and spatial transcriptomics reveal POSTN+ cancer-associated fibroblasts correlated with immune suppression and tumour progression in non-small cell lung cancer","volume":"13","author":"Chen","year":"2023","journal-title":"Clin. Transl. Med."},{"key":"10.1016\/j.bbcan.2026.189568_bb0225","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1016\/j.ccell.2021.09.003","article-title":"Three subtypes of lung cancer fibroblasts define distinct therapeutic paradigms","volume":"39","author":"Hu","year":"2021","journal-title":"Cancer Cell"},{"key":"10.1016\/j.bbcan.2026.189568_bb0230","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1016\/j.cell.2018.01.009","article-title":"CD10(+)GPR77(+) cancer-associated fibroblasts promote cancer formation and chemoresistance by sustaining cancer stemness","volume":"172","author":"Su","year":"2018","journal-title":"Cell"},{"key":"10.1016\/j.bbcan.2026.189568_bb0235","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1016\/j.ccell.2021.06.017","article-title":"Single-cell analysis defines a pancreatic fibroblast lineage that supports anti-tumor immunity","volume":"39","author":"Hutton","year":"2021","journal-title":"Cancer Cell"},{"key":"10.1016\/j.bbcan.2026.189568_bb0240","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/j.ccr.2014.04.005","article-title":"Depletion of carcinoma-associated fibroblasts and fibrosis induces immunosuppression and accelerates pancreas cancer with reduced survival","volume":"25","author":"\u00d6zdemir Berna","year":"2014","journal-title":"Cancer Cell"},{"key":"10.1016\/j.bbcan.2026.189568_bb0245","doi-asserted-by":"crossref","DOI":"10.1098\/rstb.2013.0109","article-title":"Ion channels and transporters in the development of drug resistance in cancer cells","volume":"369","author":"Hoffmann","year":"2014","journal-title":"Philos. Trans. R. Soc. B"},{"key":"10.1016\/j.bbcan.2026.189568_bb0250","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/s00432-016-2271-8","article-title":"The ratio of cancer cells to stroma after induction therapy in the treatment of non-small cell lung cancer","volume":"143","author":"Goto","year":"2017","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"10.1016\/j.bbcan.2026.189568_bb0255","doi-asserted-by":"crossref","first-page":"3472","DOI":"10.1038\/ncomms4472","article-title":"Cancer-associated fibroblasts regulate the plasticity of lung cancer stemness via paracrine signalling","volume":"5","author":"Chen","year":"2014","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bbcan.2026.189568_bb0260","doi-asserted-by":"crossref","DOI":"10.1016\/j.lungcan.2023.107258","article-title":"Chemotherapy-induced PDL-1 expression in cancer-associated fibroblasts promotes chemoresistance in NSCLC","volume":"181","author":"Heenatigala Palliyage","year":"2023","journal-title":"Lung Cancer"},{"key":"10.1016\/j.bbcan.2026.189568_bb0265","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1016\/j.jtho.2016.05.025","article-title":"IL-6 secreted from cancer-associated fibroblasts mediates chemoresistance in NSCLC by increasing epithelial-mesenchymal transition signaling","volume":"11","author":"Shintani","year":"2016","journal-title":"J. Thorac. Oncol."},{"key":"10.1016\/j.bbcan.2026.189568_bb0270","doi-asserted-by":"crossref","DOI":"10.3390\/biom9080361","article-title":"The natural-based antitumor compound T21 decreases Survivin levels through potent STAT3 inhibition in lung Cancer models","volume":"9","author":"Mart\u00ednez-Garc\u00eda","year":"2019","journal-title":"Biomolecules"},{"key":"10.1016\/j.bbcan.2026.189568_bb0275","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1097\/JTO.0000000000000193","article-title":"Antitumor efficacy of the anti-interleukin-6 (IL-6) antibody siltuximab in mouse xenograft models of lung cancer","volume":"9","author":"Song","year":"2014","journal-title":"J. Thorac. Oncol."},{"key":"10.1016\/j.bbcan.2026.189568_bb0280","doi-asserted-by":"crossref","DOI":"10.1111\/jcmm.70025","article-title":"IL-8 from CD248-expressing cancer-associated fibroblasts generates cisplatin resistance in non-small cell lung cancer","volume":"28","author":"Wu","year":"2024","journal-title":"J. Cell. Mol. Med."},{"key":"10.1016\/j.bbcan.2026.189568_bb0285","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1007\/s13402-025-01106-0","article-title":"CAFs mediate carboplatin resistance in LUAD via CXCL12 secretion regulated by NF-\u03baB activation","volume":"48","author":"Li","year":"2025","journal-title":"Cell. Oncol. (Dordr)"},{"key":"10.1016\/j.bbcan.2026.189568_bb0290","doi-asserted-by":"crossref","DOI":"10.1038\/srep38408","article-title":"Cancer-associated fibroblasts treated with cisplatin facilitates chemoresistance of lung adenocarcinoma through IL-11\/IL-11R\/STAT3 signaling pathway","volume":"6","author":"Tao","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbcan.2026.189568_bb0295","doi-asserted-by":"crossref","first-page":"696","DOI":"10.3892\/ol.2021.12957","article-title":"Cancer-associated fibroblast-derived CCL5 contributes to cisplatin resistance in A549 NSCLC cells partially through upregulation of lncRNA HOTAIR expression","volume":"22","author":"Sun","year":"2021","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.bbcan.2026.189568_bb0300","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbamcr.2025.120029","article-title":"Cancer-associated fibroblasts secreting IL-6 inhibit the cisplatin and docetaxel killing effect in lung squamous cell carcinoma","volume":"1872","author":"Zhu","year":"2025","journal-title":"Biochim. Biophys. Acta, Mol. Cell Res."},{"key":"10.1016\/j.bbcan.2026.189568_bb0305","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1111\/cas.13998","article-title":"Cancer-associated fibroblasts contribute to cisplatin resistance by modulating ANXA3 in lung cancer cells","volume":"110","author":"Wang","year":"2019","journal-title":"Cancer Sci."},{"key":"10.1016\/j.bbcan.2026.189568_bb0310","doi-asserted-by":"crossref","first-page":"10613","DOI":"10.1038\/s41598-017-10873-2","article-title":"Gas6 derived from cancer-associated fibroblasts promotes migration of Axl-expressing lung cancer cells during chemotherapy","volume":"7","author":"Kanzaki","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbcan.2026.189568_bb0315","doi-asserted-by":"crossref","DOI":"10.1002\/ctm2.989","article-title":"Cancer-associated fibroblast-derived exosomal microRNA-20a suppresses the PTEN\/PI3K-AKT pathway to promote the progression and chemoresistance of non-small cell lung cancer","volume":"12","author":"Shi","year":"2022","journal-title":"Clin. Transl. Med."},{"key":"10.1016\/j.bbcan.2026.189568_bb0320","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0129593","article-title":"Cancer associated fibroblast-derived hepatocyte growth factor inhibits the paclitaxel-induced apoptosis of lung Cancer A549 cells by up-regulating the PI3K\/Akt and GRP78 signaling on a microfluidic platform","volume":"10","author":"Ying","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.bbcan.2026.189568_bb0325","doi-asserted-by":"crossref","first-page":"2860","DOI":"10.7150\/thno.51797","article-title":"Cisplatin-resistant NSCLC cells induced by hypoxia transmit resistance to sensitive cells through exosomal PKM2","volume":"11","author":"Wang","year":"2021","journal-title":"Theranostics"},{"key":"10.1016\/j.bbcan.2026.189568_bb0330","doi-asserted-by":"crossref","first-page":"13220","DOI":"10.18632\/aging.103429","article-title":"Cancer-associated fibroblasts-derived gamma-glutamyltransferase 5 promotes tumor growth and drug resistance in lung adenocarcinoma","volume":"12","author":"Wei","year":"2020","journal-title":"Aging (Albany NY)"},{"key":"10.1016\/j.bbcan.2026.189568_bb0335","doi-asserted-by":"crossref","first-page":"2793","DOI":"10.1038\/s41467-022-30484-4","article-title":"PRRX1 is a master transcription factor of stromal fibroblasts for myofibroblastic lineage progression","volume":"13","author":"Lee","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bbcan.2026.189568_bb0340","doi-asserted-by":"crossref","first-page":"2984","DOI":"10.1111\/jcmm.14205","article-title":"Inhibition of PAI-1 limits chemotherapy resistance in lung cancer through suppressing myofibroblast characteristics of cancer-associated fibroblasts","volume":"23","author":"Masuda","year":"2019","journal-title":"J. Cell. Mol. Med."},{"key":"10.1016\/j.bbcan.2026.189568_bb0345","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2025.1545762","article-title":"Multi-omics analysis of the dynamic role of STAR+ cells in regulating platinum-based chemotherapy responses and tumor microenvironment in serous ovarian carcinoma","volume":"16","author":"Lan","year":"2025","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.bbcan.2026.189568_bb0350","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1097\/SLA.0000000000006416","article-title":"Tumor-intrinsic and cancer-associated fibroblast subtypes independently predict outcomes in pancreatic cancer","volume":"280","author":"Lee","year":"2024","journal-title":"Ann. Surg."},{"key":"10.1016\/j.bbcan.2026.189568_bb0355","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/1748-717X-7-59","article-title":"Cancer-associated fibroblasts from human NSCLC survive ablative doses of radiation but their invasive capacity is reduced","volume":"7","author":"Hellevik","year":"2012","journal-title":"Radiat. Oncol."},{"key":"10.1016\/j.bbcan.2026.189568_bb0360","article-title":"Senescent fibroblasts generate a CAF phenotype through the Stat3 pathway","volume":"13","author":"Li","year":"2022","journal-title":"Genes (Basel)"},{"key":"10.1016\/j.bbcan.2026.189568_bb0365","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.146334","article-title":"Targeting senescence-like fibroblasts radiosensitizes non-small cell lung cancer and reduces radiation-induced pulmonary fibrosis","volume":"6","author":"Meng","year":"2021","journal-title":"JCI Insight"},{"key":"10.1016\/j.bbcan.2026.189568_bb0370","doi-asserted-by":"crossref","first-page":"87","DOI":"10.3389\/fonc.2015.00087","article-title":"Cancer-associated fibroblasts from lung tumors maintain their immunosuppressive abilities after high-dose irradiation","volume":"5","author":"Gorchs","year":"2015","journal-title":"Front. Oncol."},{"key":"10.1016\/j.bbcan.2026.189568_bb0375","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1433237","article-title":"Immunological signatures from irradiated cancer-associated fibroblasts","volume":"15","author":"Berzaghi","year":"2024","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bbcan.2026.189568_bb0380","doi-asserted-by":"crossref","DOI":"10.3390\/cancers11050689","article-title":"Fibroblast-mediated immunoregulation of macrophage function is maintained after irradiation","volume":"11","author":"Berzaghi","year":"2019","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.bbcan.2026.189568_bb0385","first-page":"90","article-title":"The tumor microenvironment and radiotherapy response; a central role for cancer-associated fibroblasts","volume":"22","author":"Ansems","year":"2020","journal-title":"Clin. Transl. Radiat. Oncol."},{"key":"10.1016\/j.bbcan.2026.189568_bb0390","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbadis.2023.166670","article-title":"Cancer-associated fibroblasts facilitate DNA damage repair by promoting the glycolysis in non-small cell lung cancer","volume":"1869","author":"Zhang","year":"2023","journal-title":"Biochim. Biophys. Acta Mol. basis Dis."},{"key":"10.1016\/j.bbcan.2026.189568_bb0395","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1007\/s10616-025-00713-x","article-title":"Cancer-associated fibroblast-derived exosomal FAM83F regulates KIF23 expression to promote the malignant progression and reduce radiosensitivity in non-small cell lung cancer","volume":"77","author":"Li","year":"2025","journal-title":"Cytotechnology"},{"key":"10.1016\/j.bbcan.2026.189568_bb0400","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1002\/kjm2.12673","article-title":"Exosomal miR-196a-5p enhances radioresistance in lung cancer cells by downregulating NFKBIA","volume":"39","author":"Yao","year":"2023","journal-title":"Kaohsiung J. Med. Sci."},{"key":"10.1016\/j.bbcan.2026.189568_bb0405","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1186\/s12967-024-05057-2","article-title":"Single-cell transcriptomic sequencing data reveal aberrant DNA methylation in SMAD3 promoter region in tumor-associated fibroblasts affecting molecular mechanism of radiosensitivity in non-small cell lung cancer","volume":"22","author":"Han","year":"2024","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.bbcan.2026.189568_bb0410","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2025.116807","article-title":"Cancer-associated fibroblast-derived fibulin-5 promotes radioresistance in non-small-cell lung cancer","volume":"44","author":"Zhang","year":"2025","journal-title":"Cell Rep."},{"key":"10.1016\/j.bbcan.2026.189568_bb0415","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2024.123188","article-title":"Cytological changes in radiation-induced lung injury","volume":"358","author":"Wang","year":"2024","journal-title":"Life Sci."},{"key":"10.1016\/j.bbcan.2026.189568_bb0420","doi-asserted-by":"crossref","DOI":"10.1016\/j.jconrel.2025.114199","article-title":"Targeting HMGB1 modulates cancer-associated fibroblasts and enhances radiotherapy in lung adenocarcinoma","volume":"387","author":"Hao","year":"2025","journal-title":"J. Control. Release"},{"key":"10.1016\/j.bbcan.2026.189568_bb0425","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1186\/s12935-023-02990-y","article-title":"Recent advances in non-small cell lung cancer targeted therapy; an update review","volume":"23","author":"Araghi","year":"2023","journal-title":"Cancer Cell Int."},{"key":"10.1016\/j.bbcan.2026.189568_bb0430","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/j.bbadis.2017.12.021","article-title":"Cancer-associated fibroblasts promote epithelial-mesenchymal transition and EGFR-TKI resistance of non-small cell lung cancers via HGF\/IGF-1\/ANXA2 signaling","volume":"1864","author":"Yi","year":"2018","journal-title":"Biochim. Biophys. Acta Mol. basis Dis."},{"key":"10.1016\/j.bbcan.2026.189568_bb0435","doi-asserted-by":"crossref","DOI":"10.18632\/oncotarget.6293","article-title":"Implication of epithelial-mesenchymal transition in IGF1R-induced resistance to EGFR-TKIs in advanced non-small cell lung cancer","volume":"6","author":"Zhou","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.bbcan.2026.189568_bb0440","doi-asserted-by":"crossref","first-page":"3665","DOI":"10.2147\/OTT.S89659","article-title":"Crosstalk with cancer-associated fibroblasts induces resistance of non-small cell lung cancer cells to epidermal growth factor receptor tyrosine kinase inhibition","author":"Choe","year":"2015","journal-title":"Onco. Targets Ther."},{"key":"10.1016\/j.bbcan.2026.189568_bb0445","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1007\/s00109-023-02384-7","article-title":"Periostin secreted by cancer-associated fibroblasts promotes cancer progression and drug resistance in non-small cell lung cancer","volume":"101","author":"Takatsu","year":"2023","journal-title":"J. Mol. Med."},{"key":"10.1016\/j.bbcan.2026.189568_bb0450","doi-asserted-by":"crossref","first-page":"3428","DOI":"10.1111\/cas.15502","article-title":"Drug repositioning of tranilast to sensitize a cancer therapy by targeting cancer-associated fibroblast","volume":"113","author":"Ochi","year":"2022","journal-title":"Cancer Sci."},{"key":"10.1016\/j.bbcan.2026.189568_bb0455","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/s40170-025-00400-7","article-title":"Cancer-associated fibroblasts promote drug resistance in ALK-driven lung adenocarcinoma cells by upregulating lipid biosynthesis","volume":"13","author":"Daum","year":"2025","journal-title":"Cancer Metab."},{"key":"10.1016\/j.bbcan.2026.189568_bb0460","doi-asserted-by":"crossref","DOI":"10.1186\/s12885-022-09877-7","article-title":"Cancer-associated fibroblasts strengthen cell proliferation and EGFR TKIs resistance through aryl hydrocarbon receptor dependent signals in non-small cell lung cancer","volume":"22","author":"Feng","year":"2022","journal-title":"BMC Cancer"},{"key":"10.1016\/j.bbcan.2026.189568_bb0465","doi-asserted-by":"crossref","DOI":"10.18632\/aging.202547","article-title":"MET inhibitor, capmatinib overcomes osimertinib resistance via suppression of MET\/Akt\/snail signaling in non-small cell lung cancer and decreased generation of cancer-associated fibroblasts","volume":"13","author":"Zhu","year":"2021","journal-title":"Aging"},{"key":"10.1016\/j.bbcan.2026.189568_bb0470","doi-asserted-by":"crossref","DOI":"10.1186\/s12967-024-06064-z","article-title":"Cancer-associated fibroblasts induce almonertinib resistance in non-small cell lung cancer","volume":"23","author":"Wei","year":"2025","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.bbcan.2026.189568_bb0475","doi-asserted-by":"crossref","DOI":"10.1186\/s40164-025-00616-9","article-title":"Dickkopf-1 promotes tumor progression of gefitinib-resistant non-small cell lung cancer through cancer cell-fibroblast interactions","volume":"14","author":"Choi","year":"2025","journal-title":"Exp. Hematol. Oncol."},{"key":"10.1016\/j.bbcan.2026.189568_bb0480","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1038\/s41388-025-03318-y","article-title":"Cancer-associated fibroblasts promote EGFR-TKI resistance via the CTHRC1\/glycolysis\/H3K18la positive feedback loop","volume":"44","author":"Zhang","year":"2025","journal-title":"Oncogene"},{"key":"10.1016\/j.bbcan.2026.189568_bb0485","doi-asserted-by":"crossref","DOI":"10.1002\/ctm2.70281","article-title":"Transitional CXCL14(+) cancer-associated fibroblasts enhance tumour metastasis and confer resistance to EGFR-TKIs, revealing therapeutic vulnerability to filgotinib in lung adenocarcinoma","volume":"15","author":"Xu","year":"2025","journal-title":"Clin. Transl. Med."},{"key":"10.1016\/j.bbcan.2026.189568_bb0490","doi-asserted-by":"crossref","DOI":"10.1038\/srep46662","article-title":"CD200-positive cancer associated fibroblasts augment the sensitivity of epidermal growth factor receptor mutation-positive lung adenocarcinomas to EGFR tyrosine kinase inhibitors","volume":"7","author":"Ishibashi","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbcan.2026.189568_bb0495","doi-asserted-by":"crossref","DOI":"10.1186\/s12943-023-01740-y","article-title":"Lung cancer immunotherapy: progress, pitfalls, and promises","volume":"22","author":"Lahiri","year":"2023","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.bbcan.2026.189568_bb0500","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.jtho.2022.10.003","article-title":"Treatment characteristics and real-world progression-free survival in patients with unresectable stage III NSCLC who received durvalumab after chemoradiotherapy: findings from the PACIFIC-R study","volume":"18","author":"Girard","year":"2023","journal-title":"J. Thorac. Oncol."},{"key":"10.1016\/j.bbcan.2026.189568_bb0505","doi-asserted-by":"crossref","DOI":"10.26508\/lsa.202101230","article-title":"Meflin-positive cancer-associated fibroblasts enhance tumor response to immune checkpoint blockade","volume":"5","author":"Miyai","year":"2022","journal-title":"Life Sci. Alliance"},{"key":"10.1016\/j.bbcan.2026.189568_bb0510","doi-asserted-by":"crossref","DOI":"10.3390\/cancers12123650","article-title":"TGF-\u03b2 mediated immune evasion in cancer-spotlight on cancer-associated fibroblasts","volume":"12","author":"Ghahremanifard","year":"2020","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.bbcan.2026.189568_bb0515","doi-asserted-by":"crossref","DOI":"10.1111\/jcmm.70025","article-title":"CD248-expressing cancer-associated fibroblasts induce non-small cell lung cancer metastasis via hippo pathway-mediated extracellular matrix stiffness","volume":"28","author":"Wu","year":"2024","journal-title":"J. Cell. Mol. Med."},{"key":"10.1016\/j.bbcan.2026.189568_bb0520","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1158\/1535-7163.MCT-22-0595","article-title":"Interplay between extracellular matrix remodeling and angiogenesis in tumor ecosystem","volume":"22","author":"Siddhartha","year":"2023","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.bbcan.2026.189568_bb0525","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.matbio.2023.04.002","article-title":"Tumor-associated fibrosis impairs the response to immunotherapy","volume":"119","author":"Naik","year":"2023","journal-title":"Matrix Biol."},{"key":"10.1016\/j.bbcan.2026.189568_bb0530","doi-asserted-by":"crossref","first-page":"3104","DOI":"10.7150\/thno.69590","article-title":"Multi-scale integrative analyses identify THBS2(+) cancer-associated fibroblasts as a key orchestrator promoting aggressiveness in early-stage lung adenocarcinoma","volume":"12","author":"Yang","year":"2022","journal-title":"Theranostics"},{"key":"10.1016\/j.bbcan.2026.189568_bb0535","doi-asserted-by":"crossref","DOI":"10.3390\/cancers11050705","article-title":"LOXL1 is regulated by integrin \u03b111 and promotes non-small cell lung cancer tumorigenicity","volume":"11","author":"Zeltz","year":"2019","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.bbcan.2026.189568_bb0540","article-title":"Machine learning identifies characteristics molecules of cancer associated fibroblasts significantly correlated with the prognosis, immunotherapy response and immune microenvironment in lung adenocarcinoma","volume":"12","author":"Wang","year":"2022","journal-title":"Front. Oncol."},{"key":"10.1016\/j.bbcan.2026.189568_bb0545","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2024.105003","article-title":"Tumoral and stromal hMENA isoforms impact tertiary lymphoid structure localization in lung cancer and predict immune checkpoint blockade response in patients with cancer","volume":"101","author":"Di Modugno","year":"2024","journal-title":"EBioMedicine"},{"key":"10.1016\/j.bbcan.2026.189568_bb0550","doi-asserted-by":"crossref","first-page":"4571","DOI":"10.1158\/0008-5472.CAN-22-0435","article-title":"ATM regulates differentiation of myofibroblastic cancer-associated fibroblasts and can be targeted to overcome immunotherapy resistance","volume":"82","author":"Mellone","year":"2022","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbcan.2026.189568_bb0555","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2025-011648","article-title":"FMO2(+) cancer-associated fibroblasts sensitize anti-PD-1 therapy in patients with hepatocellular carcinoma","volume":"13","author":"Xu","year":"2025","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.bbcan.2026.189568_bb0560","doi-asserted-by":"crossref","first-page":"2175","DOI":"10.1038\/s41467-025-57465-7","article-title":"Antigen-presenting cancer associated fibroblasts enhance antitumor immunity and predict immunotherapy response","volume":"16","author":"Song","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bbcan.2026.189568_bb0565","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.semcancer.2013.12.005","article-title":"Regulation of the anti-tumour immune response by cancer-associated fibroblasts","volume":"25","author":"Harper","year":"2014","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.bbcan.2026.189568_bb0570","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2018.00414","article-title":"Alteration of the antitumor immune response by cancer-associated fibroblasts","volume":"9","author":"Ziani","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bbcan.2026.189568_bb0575","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.ccr.2009.12.041","article-title":"Cancer-associated fibroblasts are activated in incipient neoplasia to orchestrate tumor-promoting inflammation in an NF-&#x3ba;B-dependent manner","volume":"17","author":"Erez","year":"2010","journal-title":"Cancer Cell"},{"key":"10.1016\/j.bbcan.2026.189568_bb0580","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1186\/s12943-021-01428-1","article-title":"Crosstalk between cancer-associated fibroblasts and immune cells in the tumor microenvironment: new findings and future perspectives","volume":"20","author":"Mao","year":"2021","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.bbcan.2026.189568_bb0585","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2023.1295442","article-title":"Cellular crosstalk of macrophages and therapeutic implications in non-small cell lung cancer revealed by integrative inference of single-cell transcriptomics","volume":"14","author":"Wu","year":"2023","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.bbcan.2026.189568_bb0590","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.1002\/tox.23821","article-title":"Identifying potential targets for lung cancer intervention by analyzing the crosstalk of cancer-associated fibroblasts and immune and metabolism microenvironment","volume":"38","author":"Wei","year":"2023","journal-title":"Environ. Toxicol."},{"key":"10.1016\/j.bbcan.2026.189568_bb0595","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbadis.2022.166521","article-title":"CXCL12 derived from CD248-expressing cancer-associated fibroblasts mediates M2-polarized macrophages to promote nonsmall cell lung cancer progression","volume":"1868","author":"Wu","year":"2022","journal-title":"Biochim. Biophys. Acta Mol. basis Dis."},{"key":"10.1016\/j.bbcan.2026.189568_bb0600","article-title":"CD248-expressing cancer-associated fibroblasts induce epithelial\u2013mesenchymal transition of non-small cell lung cancer via inducing M2-polarized macrophages","volume":"14","author":"Xiao","year":"2024","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbcan.2026.189568_bb0605","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.adh8005","article-title":"Tumor-associated fibrosis impairs immune surveillance and response to immune checkpoint blockade in non\u2013small cell lung cancer","volume":"15","author":"Herzog","year":"2023","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.bbcan.2026.189568_bb0610","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2020.107802","article-title":"Fibroblast-derived STC-1 modulates tumor-associated macrophages and lung adenocarcinoma development","volume":"31","author":"Kamata","year":"2020","journal-title":"Cell Rep."},{"key":"10.1016\/j.bbcan.2026.189568_bb0615","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.lungcan.2020.12.020","article-title":"Relationship between podoplanin-expressing cancer-associated fibroblasts and the immune microenvironment of early lung squamous cell carcinoma","volume":"153","author":"Suzuki","year":"2021","journal-title":"Lung Cancer"},{"key":"10.1016\/j.bbcan.2026.189568_bb0620","doi-asserted-by":"crossref","first-page":"2646","DOI":"10.21037\/tlcr-2025-244","article-title":"Single-cell and spatial transcriptomics profile the interaction of SPP1+ macrophages and FAP+ fibroblasts in non-small cell lung cancer","volume":"14","author":"Xiao","year":"2025","journal-title":"Transl. Lung Cancer Res."},{"key":"10.1016\/j.bbcan.2026.189568_bb0625","doi-asserted-by":"crossref","first-page":"2956","DOI":"10.7150\/ijms.113580","article-title":"Integration of multi-scale profiling and machine learning reveals the prognostic role of extracellular matrix-related Cancer-associated fibroblasts in lung adenocarcinoma","volume":"22","author":"Chen","year":"2025","journal-title":"Int. J. Med. Sci."},{"key":"10.1016\/j.bbcan.2026.189568_bb0630","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1038\/nrc.2016.52","article-title":"Neutrophils in cancer: neutral no more","volume":"16","author":"Coffelt","year":"2016","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.bbcan.2026.189568_bb0635","article-title":"Cooperation between cancer and fibroblasts in vascular mimicry and N2-type neutrophil recruitment via Notch2\u2013Jagged1 interaction in lung cancer","volume":"11-2021","author":"Tsai","year":"2021","journal-title":"Front. Oncol."},{"key":"10.1016\/j.bbcan.2026.189568_bb0640","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1093\/carcin\/bgs123","article-title":"Tumor-associated neutrophils: friend or foe?","volume":"33","author":"Fridlender","year":"2012","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.bbcan.2026.189568_bb0645","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1186\/s12967-024-05017-w","article-title":"Senescent cancer-associated fibroblasts facilitate tumor associated neutrophil recruitment suppressing tumor immunity","volume":"22","author":"Lin","year":"2024","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.bbcan.2026.189568_bb0650","doi-asserted-by":"crossref","DOI":"10.1016\/j.ccell.2025.06.007","article-title":"Chemotherapy awakens dormant cancer cells in lung by inducing neutrophil extracellular traps","author":"He","year":"2025","journal-title":"Cancer Cell"},{"key":"10.1016\/j.bbcan.2026.189568_bb0655","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1007\/s00262-012-1246-0","article-title":"The roles of mast cells in anticancer immunity","volume":"61","author":"Dalton","year":"2012","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.bbcan.2026.189568_bb0660","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/s10555-011-9276-1","article-title":"Mast cell: insight into remodeling a tumor microenvironment","volume":"30","author":"Liu","year":"2011","journal-title":"Cancer Metastasis Rev."},{"key":"10.1016\/j.bbcan.2026.189568_bb0665","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1007\/s12672-024-01062-5","article-title":"Characteristics of mast cell infiltration in lung adenocarcinoma and its impact on prognosis","volume":"15","author":"Qiu","year":"2024","journal-title":"Discov. Oncol."},{"key":"10.1016\/j.bbcan.2026.189568_bb0670","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/s12964-018-0269-3","article-title":"Mast cells and mast cell tryptase enhance migration of human lung fibroblasts through protease-activated receptor 2","volume":"16","author":"Bagher","year":"2018","journal-title":"Cell Commun. Signal"},{"key":"10.1016\/j.bbcan.2026.189568_bb0675","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1165\/rcmb.2003-0282OC","article-title":"Human lung fibroblasts express interleukin-6 in response to signaling after mast cell contact","volume":"30","author":"Fitzgerald","year":"2004","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"10.1016\/j.bbcan.2026.189568_bb0680","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.662594","article-title":"Ionizing radiation curtails immunosuppressive effects from cancer-associated fibroblasts on dendritic cells","volume":"12","author":"Berzaghi","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bbcan.2026.189568_bb0685","doi-asserted-by":"crossref","first-page":"5449","DOI":"10.1158\/1078-0432.CCR-18-1543","article-title":"The intersection between tumor angiogenesis and immune suppression","volume":"25","author":"Rahma","year":"2019","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.bbcan.2026.189568_bb0690","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1038\/nm863","article-title":"Blockade of B7-H1 improves myeloid dendritic cell-mediated antitumor immunity","volume":"9","author":"Curiel","year":"2003","journal-title":"Nat. Med."},{"key":"10.1016\/j.bbcan.2026.189568_bb0695","doi-asserted-by":"crossref","DOI":"10.1038\/oncsis.2016.7","article-title":"Hepatic carcinoma-associated fibroblasts induce IDO-producing regulatory dendritic cells through IL-6-mediated STAT3 activation","volume":"5","author":"Cheng","year":"2016","journal-title":"Oncogenesis"},{"key":"10.1016\/j.bbcan.2026.189568_bb0700","doi-asserted-by":"crossref","first-page":"27584","DOI":"10.18632\/oncotarget.8488","article-title":"Lung cancer-derived galectin-1 contributes to cancer associated fibroblast-mediated cancer progression and immune suppression through TDO2\/kynurenine axis","volume":"7","author":"Hsu","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.bbcan.2026.189568_bb0705","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1084\/jem.20101876","article-title":"Intratumor T helper type 2 cell infiltrate correlates with cancer-associated fibroblast thymic stromal lymphopoietin production and reduced survival in pancreatic cancer","volume":"208","author":"De Monte","year":"2011","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.bbcan.2026.189568_bb0710","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1111\/imr.12572","article-title":"Immunomodulation by ionizing radiation-impact for design of radio-immunotherapies and for treatment of inflammatory diseases","volume":"280","author":"Frey","year":"2017","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.bbcan.2026.189568_bb0715","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1593\/tlo.12349","article-title":"Changes in the secretory profile of NSCLC-associated fibroblasts after ablative radiotherapy: potential impact on angiogenesis and tumor growth","volume":"6","author":"Hellevik","year":"2013","journal-title":"Transl. Oncol."},{"key":"10.1016\/j.bbcan.2026.189568_bb0720","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1016\/j.immuni.2022.07.001","article-title":"Lung fibroblasts facilitate pre-metastatic niche formation by remodeling the local immune microenvironment","volume":"55","author":"Gong","year":"2022","journal-title":"Immunity"},{"key":"10.1016\/j.bbcan.2026.189568_bb0725","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.semcdb.2017.01.003","article-title":"Extracellular vesicle communication pathways as regulatory targets of oncogenic transformation","volume":"67","author":"Choi","year":"2017","journal-title":"Semin. Cell Dev. Biol."},{"key":"10.1016\/j.bbcan.2026.189568_bb0730","doi-asserted-by":"crossref","first-page":"S649","DOI":"10.4103\/jcrt.jcrt_1286_22","article-title":"Curcumin mediated dendritic cell maturation by modulating cancer associated fibroblasts-derived exosomal miRNA-146a","volume":"19","author":"Mirza","year":"2023","journal-title":"J. Cancer Res. Ther."},{"key":"10.1016\/j.bbcan.2026.189568_bb0735","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1038\/s41571-023-00846-y","article-title":"Myeloid-derived suppressor cells in cancer and cancer therapy","volume":"21","author":"Lasser","year":"2024","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.bbcan.2026.189568_bb0740","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.phrs.2016.05.007","article-title":"Implications of MDSCs-targeting in lung cancer chemo-immunotherapeutics","volume":"110","author":"Adah","year":"2016","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.bbcan.2026.189568_bb0745","doi-asserted-by":"crossref","first-page":"804","DOI":"10.7150\/ijbs.19398","article-title":"Stroma-derived fibrinogen-like protein 2 activates cancer-associated fibroblasts to promote tumor growth in lung cancer","volume":"13","author":"Zhu","year":"2017","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.bbcan.2026.189568_bb0750","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1158\/2326-6066.CIR-19-0507","article-title":"Cancer-associated fibroblasts promote immunosuppression by inducing ROS-generating monocytic MDSCs in lung squamous cell carcinoma","volume":"8","author":"Xiang","year":"2020","journal-title":"Cancer Immunol. Res."},{"key":"10.1016\/j.bbcan.2026.189568_bb0755","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1084\/jem.20162024","article-title":"Distinct populations of inflammatory fibroblasts and myofibroblasts in pancreatic cancer","volume":"214","author":"\u00d6hlund","year":"2017","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.bbcan.2026.189568_bb0760","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1016\/j.ccell.2017.10.005","article-title":"Cancer-associated fibroblasts neutralize the anti-tumor effect of CSF1 receptor blockade by inducing PMN-MDSC infiltration of tumors","volume":"32","author":"Kumar","year":"2017","journal-title":"Cancer Cell"},{"key":"10.1016\/j.bbcan.2026.189568_bb0765","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1038\/onc.2016.273","article-title":"Hepatic carcinoma-associated fibroblasts enhance immune suppression by facilitating the generation of myeloid-derived suppressor cells","volume":"36","author":"Deng","year":"2017","journal-title":"Oncogene"},{"key":"10.1016\/j.bbcan.2026.189568_bb0770","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aay8456","article-title":"Selective inhibition of TGF\u03b21 activation overcomes primary resistance to checkpoint blockade therapy by altering tumor immune landscape","volume":"12","author":"Martin","year":"2020","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.bbcan.2026.189568_bb0775","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1002\/1873-3468.15083","article-title":"IFN\u03b3 and TNF\u03b1 drive an inflammatory secretion profile in cancer-associated fibroblasts from human non-small cell lung cancer","volume":"599","author":"Koppensteiner","year":"2025","journal-title":"FEBS Lett."},{"key":"10.1016\/j.bbcan.2026.189568_bb0780","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a030338","article-title":"T helper cell differentiation, heterogeneity, and plasticity","volume":"10","author":"Zhu","year":"2018","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"10.1016\/j.bbcan.2026.189568_bb0785","series-title":"Th1\/Th2 Cell\u2019s Function in Immune System","first-page":"45","author":"Zhang","year":"2014"},{"key":"10.1016\/j.bbcan.2026.189568_bb0790","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1221532","article-title":"Cancer-associated fibroblasts drive CXCL13 production in activated T cells via TGF-beta","volume":"14","author":"O\u2019Connor","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bbcan.2026.189568_bb0795","doi-asserted-by":"crossref","first-page":"4820","DOI":"10.1158\/1078-0432.CCR-18-0205","article-title":"Cancer-associated fibroblasts affect Intratumoral CD8(+) and FoxP3(+) T cells via IL6 in the tumor microenvironment","volume":"24","author":"Kato","year":"2018","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.bbcan.2026.189568_bb0800","doi-asserted-by":"crossref","unstructured":"Ringham OR, Loffredo LF, Arpaia N (2023) Investigating the interactions between regulatory T cells and cancer-associated fibroblasts and their role in lung cancer progression. J. Immunol. 210:172.103-172.103. Doi:https:\/\/doi.org\/10.4049\/jimmunol.210.Supp.172.03%J.","DOI":"10.4049\/jimmunol.210.Supp.172.03"},{"key":"10.1016\/j.bbcan.2026.189568_bb0805","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1111\/cas.12099","article-title":"Forkhead box P3 regulatory T cells coexisting with cancer associated fibroblasts are correlated with a poor outcome in lung adenocarcinoma","volume":"104","author":"Kinoshita","year":"2013","journal-title":"Cancer Sci."},{"key":"10.1016\/j.bbcan.2026.189568_bb0810","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.cell.2024.10.042","article-title":"Fibroblastic reticular cells generate protective intratumoral T-cell environments in lung cancer","volume":"188","author":"Onder","year":"2025","journal-title":"Cell"},{"key":"10.1016\/j.bbcan.2026.189568_bb0815","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2021.1940675","article-title":"T cells drive negative feedback mechanisms in cancer associated fibroblasts, promoting expression of co-inhibitory ligands, CD73 and IL-27 in non-small cell lung cancer","volume":"10","author":"O\u2019Connor","year":"2021","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.bbcan.2026.189568_bb0820","doi-asserted-by":"crossref","first-page":"5552","DOI":"10.4049\/jimmunol.178.9.5552","article-title":"Characterization of human lung tumor-associated fibroblasts and their ability to modulate the activation of tumor-associated T cells","volume":"178","author":"Nazareth","year":"2007","journal-title":"J. Immunol."},{"key":"10.1016\/j.bbcan.2026.189568_bb0825","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2025.1635915","article-title":"CD248 induces PD-L1 expression on cancer-associated fibroblasts to promote NSCLC immune escape","volume":"13","author":"Yang","year":"2025","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.bbcan.2026.189568_bb0830","doi-asserted-by":"crossref","DOI":"10.4046\/trd.2022.0129","article-title":"Immune regulatory function of cancer-associated fibroblasts in non-small cell lung cancer","volume":"86","author":"Lee","year":"2023","journal-title":"Tuberc. Respir. Dis."},{"key":"10.1016\/j.bbcan.2026.189568_bb0835","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-023-40850-5","article-title":"Desmoplastic stroma restricts T cell extravasation and mediates immune exclusion and immunosuppression in solid tumors","volume":"14","author":"Xiao","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bbcan.2026.189568_bb0840","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1038\/s41419-025-07974-6","article-title":"Targeting LINC01711 in FAP(+) cancer-associated fibroblasts overcomes lactate-mediated immunosuppression and enhances anti-PD-1 efficacy in lung adenocarcinoma","volume":"16","author":"Wang","year":"2025","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.bbcan.2026.189568_bb0845","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.lungcan.2018.10.021","article-title":"Link between tumor-promoting fibrous microenvironment and an immunosuppressive microenvironment in stage I lung adenocarcinoma","volume":"126","author":"Sakai","year":"2018","journal-title":"Lung Cancer"},{"key":"10.1016\/j.bbcan.2026.189568_bb0850","doi-asserted-by":"crossref","first-page":"4231","DOI":"10.1002\/tox.24292","article-title":"Research on the mechanism of exosomes from different sources influencing the progression of lung cancer","volume":"39","author":"Mao","year":"2024","journal-title":"Environ. Toxicol."},{"key":"10.1016\/j.bbcan.2026.189568_bb0855","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.974265","article-title":"CD8+ T cell\/cancer-associated fibroblast ratio stratifies prognostic and predictive responses to immunotherapy across multiple cancer types","volume":"13","author":"Zheng","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bbcan.2026.189568_bb0860","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2021.109422","article-title":"Immune mechanisms orchestrate tertiary lymphoid structures in tumors via cancer-associated fibroblasts","volume":"36","author":"Rodriguez","year":"2021","journal-title":"Cell Rep."},{"key":"10.1016\/j.bbcan.2026.189568_bb0865","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1186\/s40164-025-00695-8","article-title":"In-depth insight into tumor-infiltrating stromal cells linked to tertiary lymphoid structures and their prospective function in cancer immunotherapy","volume":"14","author":"Radandish","year":"2025","journal-title":"Exp. Hematol. Oncol."},{"key":"10.1016\/j.bbcan.2026.189568_bb0870","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1111\/imr.12987","article-title":"Stromal cells in tertiary lymphoid structures: architects of autoimmunity","volume":"302","author":"Asam","year":"2021","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.bbcan.2026.189568_bb0875","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1158\/2326-6066.CIR-20-0432","article-title":"Insights into tumor-associated tertiary lymphoid structures: novel targets for antitumor immunity and cancer immunotherapy","volume":"8","author":"Rodriguez","year":"2020","journal-title":"Cancer Immunol. Res."},{"key":"10.1016\/j.bbcan.2026.189568_bb0880","doi-asserted-by":"crossref","first-page":"6767","DOI":"10.1158\/1538-7445.AM2023-6767","article-title":"Abstract 6767: cancer-associated fibroblasts promote T-cell exclusion and resistance to immunotherapy in non-small cell lung cancer with tertiary lymphoid structures","volume":"83","author":"Peyraud","year":"2023","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbcan.2026.189568_bb0885","doi-asserted-by":"crossref","first-page":"7471","DOI":"10.1158\/1538-7445.AM2024-7471","article-title":"Abstract 7471: cancer-associated fibroblasts drive T cell infiltration and resistance to immunotherapy in non-small cell lung cancer with mature tertiary lymphoid structures","volume":"84","author":"Peyraud","year":"2024","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbcan.2026.189568_bb0890","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-024-64980-y","article-title":"The impact of tertiary lymphoid structures on tumor prognosis and the immune microenvironment in non-small cell lung cancer","volume":"14","author":"Weng","year":"2024","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbcan.2026.189568_bb0895","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1016\/j.ccell.2024.07.006","article-title":"CCL19-producing fibroblasts promote tertiary lymphoid structure formation enhancing anti-tumor IgG response in colorectal cancer liver metastasis","volume":"42","author":"Zhang","year":"2024","journal-title":"Cancer Cell"},{"key":"10.1016\/j.bbcan.2026.189568_bb0900","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/s13045-025-01688-0","article-title":"Cancer associated fibroblasts in cancer development and therapy","volume":"18","author":"Jia","year":"2025","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.bbcan.2026.189568_bb0905","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-67904-8","article-title":"Effects of pirfenidone targeting the tumor microenvironment and tumor-stroma interaction as a novel treatment for non-small cell lung cancer","volume":"10","author":"Fujiwara","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbcan.2026.189568_bb0910","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21197025","article-title":"Prognostic significance of stromal periostin expression in non-small cell lung cancer","volume":"21","author":"Ratajczak-Wielgomas","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbcan.2026.189568_bb0915","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-00717-5","article-title":"Periostin secreted by activated fibroblasts in idiopathic pulmonary fibrosis promotes tumorigenesis of non-small cell lung cancer","volume":"11","author":"Yamato","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbcan.2026.189568_bb0920","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S1470-2045(13)70586-2","article-title":"Docetaxel plus nintedanib versus docetaxel plus placebo in patients with previously treated non-small-cell lung cancer (LUME-Lung 1): a phase 3, double-blind, randomised controlled trial","volume":"15","author":"Reck","year":"2014","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.bbcan.2026.189568_bb0925","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1056\/NEJMoa1402584","article-title":"Efficacy and safety of nintedanib in idiopathic pulmonary fibrosis","volume":"370","author":"Richeldi","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bbcan.2026.189568_bb0930","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1038\/s41416-020-01201-z","article-title":"Nintedanib promotes antitumour immunity and shows antitumour activity in combination with PD-1 blockade in mice: potential role of cancer-associated fibroblasts","volume":"124","author":"Kato","year":"2021","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.bbcan.2026.189568_bb0935","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.phrs.2014.10.009","article-title":"Tranilast: a review of its therapeutic applications","volume":"91","author":"Darakhshan","year":"2015","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.bbcan.2026.189568_bb0940","doi-asserted-by":"crossref","DOI":"10.1038\/srep46140","article-title":"Tranilast-induced stress alleviation in solid tumors improves the efficacy of chemo- and nanotherapeutics in a size-independent manner","volume":"7","author":"Papageorgis","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbcan.2026.189568_bb0945","doi-asserted-by":"crossref","first-page":"E3091","DOI":"10.1073\/pnas.1411679111","article-title":"Stromal response to hedgehog signaling restrains pancreatic cancer progression","volume":"111","author":"Lee","year":"2014","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.bbcan.2026.189568_bb0950","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2020.582370","article-title":"Histone deacetylase inhibition in non-small cell lung cancer: hype or hope?","volume":"8","author":"Mamdani","year":"2020","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.bbcan.2026.189568_bb0955","article-title":"Dual inhibition of HDAC and tyrosine kinase signaling pathways with CUDC-907 attenuates TGF\u03b21 induced lung and tumor fibrosis","volume":"11","author":"Zhang","year":"2020","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.bbcan.2026.189568_bb0960","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1517\/14712598.2011.627850","article-title":"A humanized anti-IL-6 antibody (ALD518) in non-small cell lung cancer","volume":"11","author":"Bayliss","year":"2011","journal-title":"Expert. Opin. Biol. Ther."},{"key":"10.1016\/j.bbcan.2026.189568_bb0965","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1111\/1759-7714.13341","article-title":"The role of IL-6 in immunotherapy of non-small cell lung cancer (NSCLC) with immune-related adverse events (irAEs)","volume":"11","author":"Ke","year":"2020","journal-title":"Thorac. Cancer"},{"key":"10.1016\/j.bbcan.2026.189568_bb0970","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1002\/path.5290","article-title":"Effect of FGF\/FGFR pathway blocking on lung adenocarcinoma and its cancer-associated fibroblasts","volume":"249","author":"Hegab","year":"2019","journal-title":"J. Pathol."},{"key":"10.1016\/j.bbcan.2026.189568_bb0975","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1016\/j.jtcvs.2010.11.056","article-title":"Interaction between neoplastic cells and cancer-associated fibroblasts through the CXCL12\/CXCR4 axis: role in non\u2013small cell lung cancer tumor proliferation","volume":"141","author":"Wald","year":"2011","journal-title":"J. Thorac. Cardiovasc. Surg."},{"key":"10.1016\/j.bbcan.2026.189568_bb0980","article-title":"AMD3100 inhibits brain-specific metastasis in lung cancer via suppressing the SDF-1\/CXCR4 axis and protecting blood-brain barrier","volume":"9","author":"Li","year":"2017","journal-title":"Am. J. Transl. Res."},{"key":"10.1016\/j.bbcan.2026.189568_bb0985","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1111\/cas.13520","article-title":"Reverse of non-small cell lung cancer drug resistance induced by cancer-associated fibroblasts via a paracrine pathway","volume":"109","author":"Zhang","year":"2018","journal-title":"Cancer Sci."},{"key":"10.1016\/j.bbcan.2026.189568_bb0990","doi-asserted-by":"crossref","DOI":"10.18632\/oncotarget.11129","article-title":"Stromal remodeling by the BET bromodomain inhibitor JQ1 suppresses the progression of human pancreatic cancer","volume":"7","author":"Yamamoto","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.bbcan.2026.189568_bb0995","doi-asserted-by":"crossref","DOI":"10.1002\/mco2.152","article-title":"Glutathione peroxidase 8 expression on cancer cells and cancer-associated fibroblasts facilitates lung cancer metastasis","volume":"3","author":"Xu","year":"2022","journal-title":"MedComm"},{"key":"10.1016\/j.bbcan.2026.189568_bb1000","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.1053\/j.gastro.2022.02.035","article-title":"IRAK4 signaling drives resistance to checkpoint immunotherapy in pancreatic ductal adenocarcinoma","volume":"162","author":"Somani","year":"2022","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bbcan.2026.189568_bb1005","doi-asserted-by":"crossref","first-page":"6315","DOI":"10.1038\/s41467-020-19920-5","article-title":"TGF\u03b2-blockade uncovers stromal plasticity in tumors by revealing the existence of a subset of interferon-licensed fibroblasts","volume":"11","author":"Grauel","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bbcan.2026.189568_bb1010","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1186\/1476-4598-9-168","article-title":"Dasatinib reverses cancer-associated fibroblasts (CAFs) from primary lung carcinomas to a phenotype comparable to that of normal fibroblasts","volume":"9","author":"Haubeiss","year":"2010","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.bbcan.2026.189568_bb1015","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1080\/15548627.2023.2300913","article-title":"Targeting cancer-associated fibroblast autophagy renders pancreatic cancer eradicable with immunochemotherapy by inhibiting adaptive immune resistance","volume":"20","author":"Zhang","year":"2024","journal-title":"Autophagy"},{"key":"10.1016\/j.bbcan.2026.189568_bb1020","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.lungcan.2021.02.028","article-title":"Stromal FAP is an independent poor prognosis marker in non-small cell lung adenocarcinoma and associated with p53 mutation","volume":"155","author":"Moreno-Ruiz","year":"2021","journal-title":"Lung Cancer"},{"key":"10.1016\/j.bbcan.2026.189568_bb1025","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1158\/2326-6066.CIR-13-0027","article-title":"Targeting fibroblast activation protein in tumor stroma with chimeric antigen receptor T cells can inhibit tumor growth and augment host immunity without severe toxicity","volume":"2","author":"Wang","year":"2014","journal-title":"Cancer Immunol. Res."},{"key":"10.1016\/j.bbcan.2026.189568_bb1030","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1002\/anie.201506262","article-title":"Transformable peptide nanocarriers for expeditious drug release and effective cancer therapy via cancer-associated fibroblast activation","volume":"55","author":"Ji","year":"2016","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.bbcan.2026.189568_bb1035","article-title":"A whole-cell tumor vaccine modified to express fibroblast activation protein induces antitumor immunity against both tumor cells and cancer-associated fibroblasts","volume":"5","author":"Chen","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbcan.2026.189568_bb1040","doi-asserted-by":"crossref","first-page":"2621","DOI":"10.1007\/s00259-023-06211-6","article-title":"Fibroblast activation protein targeted radiotherapy induces an immunogenic tumor microenvironment and enhances the efficacy of PD-1 immune checkpoint inhibition","volume":"50","author":"Zboralski","year":"2023","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"10.1016\/j.bbcan.2026.189568_bb1045","doi-asserted-by":"crossref","first-page":"3420","DOI":"10.1158\/1078-0432.CCR-19-2238","article-title":"OMTX705, a novel FAP-targeting ADC demonstrates activity in chemotherapy and pembrolizumab-resistant solid tumor models","volume":"26","author":"Fabre","year":"2020","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.bbcan.2026.189568_bb1050","doi-asserted-by":"crossref","first-page":"2800","DOI":"10.1158\/0008-5472.CAN-14-3041","article-title":"Tumor-promoting desmoplasia is disrupted by depleting FAP-expressing stromal cells","volume":"75","author":"Lo","year":"2015","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbcan.2026.189568_bb1055","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.trecan.2022.03.001","article-title":"Targeting CAFs to overcome anticancer therapeutic resistance","volume":"8","author":"Saw","year":"2022","journal-title":"Trends Cancer"},{"key":"10.1016\/j.bbcan.2026.189568_bb1060","doi-asserted-by":"crossref","DOI":"10.1002\/ctm2.694","article-title":"Single-cell RNA sequencing technologies and applications: a brief overview","volume":"12","author":"Jovic","year":"2022","journal-title":"Clin. Transl. Med."},{"key":"10.1016\/j.bbcan.2026.189568_bb1065","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1038\/s41586-024-07359-3","article-title":"3D genomic mapping reveals multifocality of human pancreatic precancers","volume":"629","author":"Braxton","year":"2024","journal-title":"Nature"},{"key":"10.1016\/j.bbcan.2026.189568_bb1070","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202309355","article-title":"Personalized cancer nanomedicine: overcoming biological barriers for intracellular delivery of biopharmaceuticals","volume":"36","author":"L\u00f3pez-Est\u00e9vez","year":"2024","journal-title":"Adv. Mater."}],"container-title":["Biochimica et Biophysica Acta (BBA) - Reviews on Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304419X26000405?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304419X26000405?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,21]],"date-time":"2026-06-21T08:43:03Z","timestamp":1782031383000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304419X26000405"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":214,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["S0304419X26000405"],"URL":"https:\/\/doi.org\/10.1016\/j.bbcan.2026.189568","relation":{},"ISSN":["0304-419X"],"issn-type":[{"value":"0304-419X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cancer-associated fibroblasts in non-small cell lung cancer therapy: Challenges and opportunities","name":"articletitle","label":"Article Title"},{"value":"Biochimica et Biophysica Acta (BBA) - Reviews on Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbcan.2026.189568","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"189568"}}